Plasma phospholipid omega-3 fatty acids and incidence of postoperative atrial fibrillation in the OPERA trial.
Identifieur interne : 000200 ( PubMed/Curation ); précédent : 000199; suivant : 000201Plasma phospholipid omega-3 fatty acids and incidence of postoperative atrial fibrillation in the OPERA trial.
Auteurs : Jason H Y. Wu [États-Unis] ; Roberto Marchioli ; Maria G. Silletta ; Alejandro Macchia ; Xiaoling Song ; David S. Siscovick ; William S. Harris ; Serge Masson ; Roberto Latini ; Christine Albert ; Nancy J. Brown ; Mauro Lamarra ; Roberto R. Favaloro ; Dariush MozaffarianSource :
- Journal of the American Heart Association ; 2013.
English descriptors
- KwdEn :
- Aged, Atrial Fibrillation (blood), Atrial Fibrillation (epidemiology), Cardiac Surgical Procedures, Dietary Supplements, Docosahexaenoic Acids (blood), Eicosapentaenoic Acid (blood), Fatty Acids, Unsaturated (blood), Female, Fish Oils (administration & dosage), Humans, Incidence, Male, Middle Aged, Postoperative Complications (blood), Postoperative Complications (epidemiology), Prospective Studies.
- MESH :
- chemical , administration & dosage : Fish Oils.
- chemical , blood : Docosahexaenoic Acids, Eicosapentaenoic Acid, Fatty Acids, Unsaturated.
- blood : Atrial Fibrillation, Postoperative Complications.
- epidemiology : Atrial Fibrillation, Postoperative Complications.
- Aged, Cardiac Surgical Procedures, Dietary Supplements, Female, Humans, Incidence, Male, Middle Aged, Prospective Studies.
Abstract
Long-chain polyunsaturated omega-3 fatty acids (n-3 PUFA) demonstrated antiarrhythmic potential in experimental studies. In a large multinational randomized trial (OPERA), perioperative fish oil supplementation did not reduce the risk of postoperative atrial fibrillation (PoAF) in cardiac surgery patients. However, whether presupplementation habitual plasma phospholipid n-3 PUFA, or achieved or change in n-3 PUFA level postsupplementation are associated with lower risk of PoAF is unknown.
DOI: 10.1161/JAHA.113.000397
PubMed: 24145742
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000200
Links to Exploration step
pubmed:24145742Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Plasma phospholipid omega-3 fatty acids and incidence of postoperative atrial fibrillation in the OPERA trial.</title><author><name sortKey="Wu, Jason H Y" sort="Wu, Jason H Y" uniqKey="Wu J" first="Jason H Y" last="Wu">Jason H Y. Wu</name><affiliation wicri:level="2"><nlm:affiliation>Department of Epidemiology, Harvard School of Public Health, Boston, MA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Massachusetts</region></placeName><wicri:cityArea>Department of Epidemiology, Harvard School of Public Health, Boston</wicri:cityArea></affiliation></author><author><name sortKey="Marchioli, Roberto" sort="Marchioli, Roberto" uniqKey="Marchioli R" first="Roberto" last="Marchioli">Roberto Marchioli</name></author><author><name sortKey="Silletta, Maria G" sort="Silletta, Maria G" uniqKey="Silletta M" first="Maria G" last="Silletta">Maria G. Silletta</name></author><author><name sortKey="Macchia, Alejandro" sort="Macchia, Alejandro" uniqKey="Macchia A" first="Alejandro" last="Macchia">Alejandro Macchia</name></author><author><name sortKey="Song, Xiaoling" sort="Song, Xiaoling" uniqKey="Song X" first="Xiaoling" last="Song">Xiaoling Song</name></author><author><name sortKey="Siscovick, David S" sort="Siscovick, David S" uniqKey="Siscovick D" first="David S" last="Siscovick">David S. Siscovick</name></author><author><name sortKey="Harris, William S" sort="Harris, William S" uniqKey="Harris W" first="William S" last="Harris">William S. Harris</name></author><author><name sortKey="Masson, Serge" sort="Masson, Serge" uniqKey="Masson S" first="Serge" last="Masson">Serge Masson</name></author><author><name sortKey="Latini, Roberto" sort="Latini, Roberto" uniqKey="Latini R" first="Roberto" last="Latini">Roberto Latini</name></author><author><name sortKey="Albert, Christine" sort="Albert, Christine" uniqKey="Albert C" first="Christine" last="Albert">Christine Albert</name></author><author><name sortKey="Brown, Nancy J" sort="Brown, Nancy J" uniqKey="Brown N" first="Nancy J" last="Brown">Nancy J. Brown</name></author><author><name sortKey="Lamarra, Mauro" sort="Lamarra, Mauro" uniqKey="Lamarra M" first="Mauro" last="Lamarra">Mauro Lamarra</name></author><author><name sortKey="Favaloro, Roberto R" sort="Favaloro, Roberto R" uniqKey="Favaloro R" first="Roberto R" last="Favaloro">Roberto R. Favaloro</name></author><author><name sortKey="Mozaffarian, Dariush" sort="Mozaffarian, Dariush" uniqKey="Mozaffarian D" first="Dariush" last="Mozaffarian">Dariush Mozaffarian</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2013">2013</date><idno type="doi">10.1161/JAHA.113.000397</idno><idno type="RBID">pubmed:24145742</idno><idno type="pmid">24145742</idno><idno type="wicri:Area/PubMed/Corpus">000200</idno><idno type="wicri:Area/PubMed/Curation">000200</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Plasma phospholipid omega-3 fatty acids and incidence of postoperative atrial fibrillation in the OPERA trial.</title><author><name sortKey="Wu, Jason H Y" sort="Wu, Jason H Y" uniqKey="Wu J" first="Jason H Y" last="Wu">Jason H Y. Wu</name><affiliation wicri:level="2"><nlm:affiliation>Department of Epidemiology, Harvard School of Public Health, Boston, MA.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Massachusetts</region></placeName><wicri:cityArea>Department of Epidemiology, Harvard School of Public Health, Boston</wicri:cityArea></affiliation></author><author><name sortKey="Marchioli, Roberto" sort="Marchioli, Roberto" uniqKey="Marchioli R" first="Roberto" last="Marchioli">Roberto Marchioli</name></author><author><name sortKey="Silletta, Maria G" sort="Silletta, Maria G" uniqKey="Silletta M" first="Maria G" last="Silletta">Maria G. Silletta</name></author><author><name sortKey="Macchia, Alejandro" sort="Macchia, Alejandro" uniqKey="Macchia A" first="Alejandro" last="Macchia">Alejandro Macchia</name></author><author><name sortKey="Song, Xiaoling" sort="Song, Xiaoling" uniqKey="Song X" first="Xiaoling" last="Song">Xiaoling Song</name></author><author><name sortKey="Siscovick, David S" sort="Siscovick, David S" uniqKey="Siscovick D" first="David S" last="Siscovick">David S. Siscovick</name></author><author><name sortKey="Harris, William S" sort="Harris, William S" uniqKey="Harris W" first="William S" last="Harris">William S. Harris</name></author><author><name sortKey="Masson, Serge" sort="Masson, Serge" uniqKey="Masson S" first="Serge" last="Masson">Serge Masson</name></author><author><name sortKey="Latini, Roberto" sort="Latini, Roberto" uniqKey="Latini R" first="Roberto" last="Latini">Roberto Latini</name></author><author><name sortKey="Albert, Christine" sort="Albert, Christine" uniqKey="Albert C" first="Christine" last="Albert">Christine Albert</name></author><author><name sortKey="Brown, Nancy J" sort="Brown, Nancy J" uniqKey="Brown N" first="Nancy J" last="Brown">Nancy J. Brown</name></author><author><name sortKey="Lamarra, Mauro" sort="Lamarra, Mauro" uniqKey="Lamarra M" first="Mauro" last="Lamarra">Mauro Lamarra</name></author><author><name sortKey="Favaloro, Roberto R" sort="Favaloro, Roberto R" uniqKey="Favaloro R" first="Roberto R" last="Favaloro">Roberto R. Favaloro</name></author><author><name sortKey="Mozaffarian, Dariush" sort="Mozaffarian, Dariush" uniqKey="Mozaffarian D" first="Dariush" last="Mozaffarian">Dariush Mozaffarian</name></author></analytic><series><title level="j">Journal of the American Heart Association</title><idno type="e-ISSN">2047-9980</idno><imprint><date when="2013" type="published">2013</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term><term>Atrial Fibrillation (blood)</term><term>Atrial Fibrillation (epidemiology)</term><term>Cardiac Surgical Procedures</term><term>Dietary Supplements</term><term>Docosahexaenoic Acids (blood)</term><term>Eicosapentaenoic Acid (blood)</term><term>Fatty Acids, Unsaturated (blood)</term><term>Female</term><term>Fish Oils (administration & dosage)</term><term>Humans</term><term>Incidence</term><term>Male</term><term>Middle Aged</term><term>Postoperative Complications (blood)</term><term>Postoperative Complications (epidemiology)</term><term>Prospective Studies</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Fish Oils</term></keywords><keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Docosahexaenoic Acids</term><term>Eicosapentaenoic Acid</term><term>Fatty Acids, Unsaturated</term></keywords><keywords scheme="MESH" qualifier="blood" xml:lang="en"><term>Atrial Fibrillation</term><term>Postoperative Complications</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Atrial Fibrillation</term><term>Postoperative Complications</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Cardiac Surgical Procedures</term><term>Dietary Supplements</term><term>Female</term><term>Humans</term><term>Incidence</term><term>Male</term><term>Middle Aged</term><term>Prospective Studies</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Long-chain polyunsaturated omega-3 fatty acids (n-3 PUFA) demonstrated antiarrhythmic potential in experimental studies. In a large multinational randomized trial (OPERA), perioperative fish oil supplementation did not reduce the risk of postoperative atrial fibrillation (PoAF) in cardiac surgery patients. However, whether presupplementation habitual plasma phospholipid n-3 PUFA, or achieved or change in n-3 PUFA level postsupplementation are associated with lower risk of PoAF is unknown.</div></front></TEI><pubmed><MedlineCitation Owner="NLM" Status="MEDLINE"><PMID Version="1">24145742</PMID><DateCreated><Year>2013</Year><Month>10</Month><Day>22</Day></DateCreated><DateCompleted><Year>2014</Year><Month>01</Month><Day>06</Day></DateCompleted><DateRevised><Year>2015</Year><Month>04</Month><Day>22</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2047-9980</ISSN><JournalIssue CitedMedium="Internet"><Volume>2</Volume><Issue>5</Issue><PubDate><Year>2013</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Journal of the American Heart Association</Title><ISOAbbreviation>J Am Heart Assoc</ISOAbbreviation></Journal><ArticleTitle>Plasma phospholipid omega-3 fatty acids and incidence of postoperative atrial fibrillation in the OPERA trial.</ArticleTitle><Pagination><MedlinePgn>e000397</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1161/JAHA.113.000397</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Long-chain polyunsaturated omega-3 fatty acids (n-3 PUFA) demonstrated antiarrhythmic potential in experimental studies. In a large multinational randomized trial (OPERA), perioperative fish oil supplementation did not reduce the risk of postoperative atrial fibrillation (PoAF) in cardiac surgery patients. However, whether presupplementation habitual plasma phospholipid n-3 PUFA, or achieved or change in n-3 PUFA level postsupplementation are associated with lower risk of PoAF is unknown.</AbstractText><AbstractText Label="METHODS AND RESULTS" NlmCategory="RESULTS">In 564 subjects undergoing cardiac surgery between August 2010 and June 2012 in 28 centers across 3 countries, plasma phospholipid levels of eicosapentaenoic acid (EPA), docosapentaenoic acid (DPA), and docosahexaenoic acid (DHA) were measured at enrollment and again on the morning of cardiac surgery following fish oil or placebo supplementation (10 g over 3 to 5 days, or 8 g over 2 days). The primary endpoint was incident PoAF lasting ≥ 30 seconds, centrally adjudicated, and confirmed by rhythm strip or ECG. Secondary endpoints included sustained (≥ 1 hour), symptomatic, or treated PoAF; the time to first PoAF; and the number of PoAF episodes per patient. PoAF outcomes were assessed until hospital discharge or postoperative day 10, whichever occurred first. Relative to the baseline, fish oil supplementation increased phospholipid concentrations of EPA (+142%), DPA (+13%), and DHA (+22%) (P < 0.001 each). Substantial interindividual variability was observed for change in total n-3 PUFA (range = -0.7% to 7.5% after 5 days of supplementation). Neither individual nor total circulating n-3 PUFA levels at enrollment, morning of surgery, or change between these time points were associated with risk of PoAF. The multivariable-adjusted OR (95% CI) across increasing quartiles of total n-3 PUFA at enrollment were 1.0, 1.06 (0.60 to 1.90), 1.35 (0.76 to 2.38), and 1.19 (0.64 to 2.20); and for changes in n-3 PUFA between enrollment and the morning of surgery were 1.0, 0.78 (0.44 to 1.39), 0.89 (0.51 to 1.55), and 1.01 (0.58 to 1.75). In stratified analysis, demographic, medication, and cardiac parameters did not significantly modify these associations. Findings were similar for secondary PoAF endpoints.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Among patients undergoing cardiac surgery, neither higher habitual circulating n-3 PUFA levels, nor achieved levels or changes following short-term fish oil supplementation are associated with risk of PoAF.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Jason H Y</ForeName><Initials>JH</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, Harvard School of Public Health, Boston, MA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marchioli</LastName><ForeName>Roberto</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Silletta</LastName><ForeName>Maria G</ForeName><Initials>MG</Initials></Author><Author ValidYN="Y"><LastName>Macchia</LastName><ForeName>Alejandro</ForeName><Initials>A</Initials></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Xiaoling</ForeName><Initials>X</Initials></Author><Author ValidYN="Y"><LastName>Siscovick</LastName><ForeName>David S</ForeName><Initials>DS</Initials></Author><Author ValidYN="Y"><LastName>Harris</LastName><ForeName>William S</ForeName><Initials>WS</Initials></Author><Author ValidYN="Y"><LastName>Masson</LastName><ForeName>Serge</ForeName><Initials>S</Initials></Author><Author ValidYN="Y"><LastName>Latini</LastName><ForeName>Roberto</ForeName><Initials>R</Initials></Author><Author ValidYN="Y"><LastName>Albert</LastName><ForeName>Christine</ForeName><Initials>C</Initials></Author><Author ValidYN="Y"><LastName>Brown</LastName><ForeName>Nancy J</ForeName><Initials>NJ</Initials></Author><Author ValidYN="Y"><LastName>Lamarra</LastName><ForeName>Mauro</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Favaloro</LastName><ForeName>Roberto R</ForeName><Initials>RR</Initials></Author><Author ValidYN="Y"><LastName>Mozaffarian</LastName><ForeName>Dariush</ForeName><Initials>D</Initials></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT00970489</AccessionNumber></AccessionNumberList></DataBank></DataBankList><GrantList CompleteYN="Y"><Grant><GrantID>1 RC2 HL101816</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D016449">Randomized Controlled Trial</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2013</Year><Month>10</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Am Heart Assoc</MedlineTA><NlmUniqueID>101580524</NlmUniqueID><ISSNLinking>2047-9980</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005231">Fatty Acids, Unsaturated</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005395">Fish Oils</NameOfSubstance></Chemical><Chemical><RegistryNumber>25167-62-8</RegistryNumber><NameOfSubstance UI="D004281">Docosahexaenoic Acids</NameOfSubstance></Chemical><Chemical><RegistryNumber>25448-00-4</RegistryNumber><NameOfSubstance UI="C026219">docosapentaenoic acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>AAN7QOV9EA</RegistryNumber><NameOfSubstance UI="D015118">Eicosapentaenoic Acid</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Lipids. 2001;36 Suppl:S111-4</RefSource><PMID Version="1">11837983</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Circ Arrhythm Electrophysiol. 2012 Oct;5(5):978-83</RefSource><PMID Version="1">22923273</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Lipid Res. 1986 Jan;27(1):114-20</RefSource><PMID Version="1">3958609</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Am Diet Assoc. 1993 Jul;93(7):790-6</RefSource><PMID Version="1">8320406</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Int J Epidemiol. 1997;26 Suppl 1:S152-60</RefSource><PMID Version="1">9126543</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Biol Chem. 1957 May;226(1):497-509</RefSource><PMID Version="1">13428781</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Chest. 2005 Aug;128(2 Suppl):9S-16S</RefSource><PMID Version="1">16167659</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur Heart J. 2006 Dec;27(23):2846-57</RefSource><PMID Version="1">17015402</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Clin Nutr. 2007 May;85(5):1222-8</RefSource><PMID Version="1">17490956</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cardiovasc Res. 2009 Feb 1;81(2):286-93</RefSource><PMID Version="1">19029136</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Circ Arrhythm Electrophysiol. 2008 Apr;1(1):62-73</RefSource><PMID Version="1">19808395</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Circulation. 2009 Dec 8;120(23):2315-21</RefSource><PMID Version="1">19933935</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Europace. 2010 Mar;12(3):356-63</RefSource><PMID Version="1">20061328</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Heart Rhythm. 2010 Apr;7(4):520-8</RefSource><PMID Version="1">20156610</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Br J Nutr. 2010 Sep;104(5):729-36</RefSource><PMID Version="1">20420756</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Cardiovasc Res. 2011 Mar 1;89(4):852-61</RefSource><PMID Version="1">21123218</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Can J Cardiol. 2011 Jan-Feb;27(1):91-7</RefSource><PMID Version="1">21329866</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Physiol Heart Circ Physiol. 2011 May;300(5):H1814-21</RefSource><PMID Version="1">21335470</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am Heart J. 2011 Jul;162(1):56-63.e3</RefSource><PMID Version="1">21742090</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Atheroscler Thromb. 2011;18(10):857-66</RefSource><PMID Version="1">21701083</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Am Coll Cardiol. 2011 Nov 8;58(20):2047-67</RefSource><PMID Version="1">22051327</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Europace. 2012 Feb;14(2):159-74</RefSource><PMID Version="1">21821851</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Nutr. 2012 Mar;142(3):614S-625S</RefSource><PMID Version="1">22279134</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Circulation. 2012 Mar 6;125(9):1084-93</RefSource><PMID Version="1">22282329</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Am J Cardiol. 2012 Oct 1;110(7):984-92</RefSource><PMID Version="1">22819432</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>JAMA. 2012 Nov 21;308(19):2001-11</RefSource><PMID Version="1">23128104</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Am Heart Assoc. 2013 Feb;2(1):e005033</RefSource><PMID Version="1">23525440</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Am Coll Cardiol. 2013 May 28;61(21):2194-6</RefSource><PMID Version="1">23541970</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur Heart J. 2003 May;24(9):881-2</RefSource><PMID Version="1">12727160</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D001281">Atrial Fibrillation</DescriptorName><QualifierName MajorTopicYN="Y" UI="Q000097">blood</QualifierName><QualifierName MajorTopicYN="Y" UI="Q000453">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="Y" UI="D006348">Cardiac Surgical Procedures</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="Y" UI="D019587">Dietary Supplements</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D004281">Docosahexaenoic Acids</DescriptorName><QualifierName MajorTopicYN="Y" UI="Q000097">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D015118">Eicosapentaenoic Acid</DescriptorName><QualifierName MajorTopicYN="Y" UI="Q000097">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D005231">Fatty Acids, Unsaturated</DescriptorName><QualifierName MajorTopicYN="Y" UI="Q000097">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D005260">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="Y" UI="D005395">Fish Oils</DescriptorName><QualifierName MajorTopicYN="N" UI="Q000008">administration & dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D015994">Incidence</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D011183">Postoperative Complications</DescriptorName><QualifierName MajorTopicYN="Y" UI="Q000097">blood</QualifierName><QualifierName MajorTopicYN="Y" UI="Q000453">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D011446">Prospective Studies</DescriptorName></MeshHeading></MeshHeadingList><OtherID Source="NLM">PMC3835252</OtherID><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">biomarker</Keyword><Keyword MajorTopicYN="N">cardiac surgery</Keyword><Keyword MajorTopicYN="N">omega‐3 fatty acids</Keyword><Keyword MajorTopicYN="N">postoperative atrial fibrillation</Keyword><Keyword MajorTopicYN="N">randomized controlled trial</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>10</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>10</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2014</Year><Month>1</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pii">jah3347</ArticleId><ArticleId IdType="doi">10.1161/JAHA.113.000397</ArticleId><ArticleId IdType="pubmed">24145742</ArticleId><ArticleId IdType="pmc">PMC3835252</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Musique/explor/OperaV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000200 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000200 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Musique
|area= OperaV1
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:24145742
|texte= Plasma phospholipid omega-3 fatty acids and incidence of postoperative atrial fibrillation in the OPERA trial.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:24145742" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a OperaV1
| This area was generated with Dilib version V0.6.21. |  |